First Header Logo Second Header Logo

Bayard Powell

Concepts (401)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
68
2019
173
8.560
Why?
Antineoplastic Combined Chemotherapy Protocols
43
2018
401
3.350
Why?
Leukemia, Promyelocytic, Acute
15
2018
21
2.880
Why?
Mutation
26
2019
466
2.120
Why?
Antineoplastic Agents
20
2018
546
1.500
Why?
MicroRNAs
19
2017
173
1.320
Why?
Middle Aged
100
2019
10872
1.270
Why?
Cytarabine
25
2018
52
1.240
Why?
Aged
81
2019
9515
1.170
Why?
Prognosis
45
2019
1363
1.100
Why?
Oxides
6
2014
15
1.050
Why?
Arsenicals
6
2014
12
1.050
Why?
Female
102
2019
18241
1.040
Why?
Treatment Outcome
49
2018
3108
1.020
Why?
Male
100
2019
17876
1.010
Why?
Adult
75
2019
8468
1.000
Why?
Gene Expression Profiling
22
2017
320
0.990
Why?
Humans
123
2019
29220
0.970
Why?
Aged, 80 and over
47
2019
3728
0.960
Why?
Disease-Free Survival
32
2019
281
0.950
Why?
Young Adult
34
2019
2413
0.920
Why?
Remission Induction
27
2018
78
0.840
Why?
Leukemia, Myeloid
12
2011
24
0.830
Why?
Geriatric Assessment
3
2016
356
0.760
Why?
Gene Expression Regulation, Leukemic
12
2014
23
0.750
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
2013
39
0.730
Why?
Adolescent
40
2019
3265
0.710
Why?
Daunorubicin
18
2018
26
0.700
Why?
Sulfides
2
2018
24
0.660
Why?
Caprylates
2
2018
25
0.660
Why?
Chromosome Aberrations
6
2019
21
0.660
Why?
fms-Like Tyrosine Kinase 3
11
2014
16
0.650
Why?
Survival Rate
25
2019
795
0.640
Why?
Deglutition Disorders
1
2016
50
0.560
Why?
Aorta, Thoracic
1
2016
72
0.550
Why?
Neoplasm Proteins
12
2017
141
0.550
Why?
Survival Analysis
21
2016
440
0.540
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
2011
12
0.520
Why?
Hematologic Neoplasms
1
2014
28
0.490
Why?
Tretinoin
7
2018
34
0.480
Why?
Myelodysplastic Syndromes
6
2017
22
0.480
Why?
Community Networks
1
2013
26
0.450
Why?
Resilience, Psychological
1
2013
15
0.450
Why?
Developing Countries
1
2013
43
0.450
Why?
Karyotyping
13
2019
27
0.440
Why?
Stress Disorders, Post-Traumatic
1
2013
43
0.440
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
4
2012
17
0.430
Why?
Drug Administration Schedule
9
2018
246
0.430
Why?
Translocation, Genetic
4
2017
17
0.420
Why?
Drug Resistance, Neoplasm
7
2018
90
0.390
Why?
Recurrence
8
2018
235
0.390
Why?
Tumor Suppressor Proteins
4
2018
72
0.370
Why?
Azacitidine
4
2016
28
0.370
Why?
Immunotoxins
3
2007
16
0.370
Why?
Neoplasm Staging
6
2018
437
0.360
Why?
Age Factors
15
2018
1110
0.360
Why?
Cytogenetic Analysis
11
2017
15
0.360
Why?
Aminoglycosides
3
2014
6
0.360
Why?
Hospitalization
2
2018
418
0.360
Why?
Piperazines
4
2011
56
0.360
Why?
Pyrimidines
4
2011
60
0.350
Why?
Hematopoietic Stem Cell Transplantation
4
2018
83
0.350
Why?
Quality of Life
2
2013
820
0.340
Why?
Acute Disease
14
2013
239
0.330
Why?
Trans-Activators
7
2011
47
0.320
Why?
Interleukin-2
4
2013
33
0.320
Why?
RNA, Neoplasm
3
2014
20
0.320
Why?
DNA-Binding Proteins
6
2016
142
0.310
Why?
DNA Mutational Analysis
7
2017
67
0.310
Why?
Risk Factors
13
2018
3550
0.300
Why?
Nuclear Proteins
8
2019
71
0.300
Why?
Prospective Studies
6
2016
2027
0.300
Why?
Antibiotics, Antineoplastic
1
2007
62
0.290
Why?
Comorbidity
5
2018
546
0.280
Why?
Diphtheria Toxin
5
2003
23
0.280
Why?
Neoplasms
4
2019
612
0.280
Why?
Chromosomes, Human, Pair 8
2
2016
13
0.270
Why?
Time Factors
10
2015
2003
0.270
Why?
Antibodies, Monoclonal
1
2007
196
0.260
Why?
Etoposide
10
2013
30
0.260
Why?
Follow-Up Studies
13
2019
2114
0.260
Why?
Mitochondria
2
2018
174
0.250
Why?
DNA Methylation
3
2014
130
0.250
Why?
Clinical Trials as Topic
6
2017
298
0.240
Why?
Methotrexate
4
2014
60
0.240
Why?
Oligonucleotide Array Sequence Analysis
10
2013
155
0.230
Why?
Bone Marrow
5
2018
60
0.230
Why?
DNA, Neoplasm
4
2017
58
0.230
Why?
Salvage Therapy
3
2015
118
0.230
Why?
Mitoxantrone
4
2018
17
0.230
Why?
Myeloid-Lymphoid Leukemia Protein
4
2012
6
0.230
Why?
Fusion Proteins, bcr-abl
4
2011
8
0.220
Why?
Thalidomide
2
2017
29
0.220
Why?
Multivariate Analysis
6
2017
638
0.220
Why?
Lymphocytosis
1
2002
1
0.220
Why?
Genetic Predisposition to Disease
6
2018
836
0.220
Why?
Depression
2
2016
383
0.210
Why?
Oncogene Proteins, Fusion
4
2016
16
0.210
Why?
Genes, Wilms Tumor
3
2010
5
0.200
Why?
Cyclosporins
4
2013
5
0.200
Why?
Cognition
2
2016
526
0.190
Why?
Proportional Hazards Models
9
2015
710
0.190
Why?
Antimetabolites, Antineoplastic
3
2009
48
0.190
Why?
Genes, Neoplasm
2
2017
18
0.190
Why?
Recombinant Fusion Proteins
5
2003
97
0.190
Why?
Cohort Studies
6
2017
1695
0.190
Why?
Cell Line
2
2018
450
0.180
Why?
Burkitt Lymphoma
2
2014
6
0.180
Why?
Retrospective Studies
10
2018
3122
0.180
Why?
Tandem Repeat Sequences
2
2012
5
0.180
Why?
Leukemia
2
2014
36
0.180
Why?
Uniparental Disomy
1
2019
1
0.180
Why?
Loss of Heterozygosity
1
2019
17
0.180
Why?
Repressor Proteins
3
2018
53
0.170
Why?
Chromosomes, Human
1
2019
9
0.170
Why?
Goals
1
2019
36
0.170
Why?
Predictive Value of Tests
5
2013
788
0.170
Why?
Gene Expression
3
2012
332
0.170
Why?
Chromosome Inversion
3
2003
3
0.170
Why?
Neurofibromin 1
1
2018
1
0.170
Why?
Hyperglycemia
1
2018
82
0.160
Why?
Cell Respiration
1
2018
22
0.160
Why?
Communication
1
2019
122
0.160
Why?
Retreatment
1
2018
40
0.160
Why?
Genetic Loci
1
2018
147
0.160
Why?
Gene Expression Regulation, Neoplastic
4
2019
249
0.160
Why?
North Carolina
2
2013
1425
0.160
Why?
Resuscitation Orders
1
2017
11
0.160
Why?
Cytogenetics
5
2019
6
0.160
Why?
CCAAT-Enhancer-Binding Proteins
4
2011
9
0.160
Why?
Proto-Oncogene Proteins
3
2014
90
0.160
Why?
Physician-Patient Relations
1
2019
169
0.160
Why?
Chromosomes, Human, Pair 15
1
2017
3
0.150
Why?
Disseminated Intravascular Coagulation
1
2017
4
0.150
Why?
Chromosomes, Human, Pair 17
1
2017
11
0.150
Why?
Endothelial Growth Factors
1
2017
12
0.150
Why?
Microsatellite Instability
1
2017
1
0.150
Why?
Oxygen Consumption
1
2018
138
0.150
Why?
Infusions, Intravenous
2
2015
85
0.150
Why?
Neoplastic Cells, Circulating
1
2017
23
0.150
Why?
Trisomy
2
2014
8
0.150
Why?
Immunologic Factors
1
2017
48
0.150
Why?
Cyclin D1
1
2016
15
0.150
Why?
Chromosomes, Human, Pair 21
1
2016
7
0.150
Why?
Cyclin D2
1
2016
7
0.150
Why?
Biopsy
1
2018
241
0.150
Why?
Protein-Tyrosine Kinases
4
2011
37
0.150
Why?
Codon
1
2016
7
0.150
Why?
Cardiovascular Abnormalities
1
2016
1
0.150
Why?
WT1 Proteins
3
2011
3
0.150
Why?
Subclavian Artery
1
2016
6
0.150
Why?
Telomerase
1
2016
21
0.140
Why?
Intensive Care Units
1
2017
118
0.140
Why?
Vascular Malformations
1
2016
8
0.140
Why?
Diverticulum
1
2016
7
0.140
Why?
Lung Neoplasms
2
2017
384
0.140
Why?
Aneurysm
1
2016
21
0.140
Why?
Neoplasm Invasiveness
1
2017
189
0.140
Why?
Hemorrhage
1
2017
91
0.140
Why?
Blood Glucose
1
2018
467
0.140
Why?
Cell Line, Tumor
2
2017
681
0.140
Why?
Naphthyridines
1
2015
5
0.140
Why?
Interferon-alpha
3
2006
69
0.130
Why?
Polymorphism, Genetic
1
2016
196
0.130
Why?
Thiazoles
1
2015
32
0.130
Why?
Naphthalimides
1
2015
1
0.130
Why?
Activities of Daily Living
1
2016
240
0.130
Why?
Mice
2
2018
2372
0.130
Why?
Neoplasms, Second Primary
1
2014
16
0.130
Why?
Colorectal Neoplasms
1
2017
208
0.130
Why?
Chromosomes, Human, Pair 9
3
2004
13
0.130
Why?
Urinary Bladder Neoplasms
1
2017
179
0.130
Why?
Polypharmacy
1
2014
20
0.120
Why?
Neoplasm Recurrence, Local
2
2015
337
0.120
Why?
Lymphoma
1
2014
36
0.120
Why?
Positron-Emission Tomography
1
2014
172
0.110
Why?
Defense Mechanisms
1
2013
3
0.110
Why?
Sick Role
1
2013
7
0.110
Why?
Personality Inventory
1
2013
18
0.110
Why?
Affective Symptoms
1
2013
16
0.110
Why?
Mood Disorders
1
2013
19
0.110
Why?
Feasibility Studies
2
2011
267
0.110
Why?
Intercellular Signaling Peptides and Proteins
1
2013
100
0.110
Why?
Chromosomes, Human, Pair 5
2
2017
15
0.110
Why?
Culture
1
2013
38
0.110
Why?
Reverse Transcriptase Polymerase Chain Reaction
6
2010
248
0.110
Why?
Secondary Prevention
1
2013
59
0.110
Why?
Disease Progression
4
2017
572
0.110
Why?
Animals
5
2018
7302
0.110
Why?
Core Binding Factor Alpha 2 Subunit
1
2012
7
0.110
Why?
Erythrocyte Transfusion
2
2017
32
0.110
Why?
Asparaginase
2
2015
5
0.110
Why?
Leukemia, B-Cell
2
2002
4
0.110
Why?
Psychometrics
1
2013
129
0.110
Why?
Recombinant Proteins
4
2017
248
0.110
Why?
Logistic Models
5
2015
729
0.110
Why?
Peripheral Blood Stem Cell Transplantation
2
2009
5
0.110
Why?
Panax
1
2012
8
0.110
Why?
Blast Crisis
1
2011
1
0.110
Why?
Infant
4
2018
973
0.100
Why?
Adaptation, Psychological
1
2013
126
0.100
Why?
Polymorphism, Single Nucleotide
2
2018
1079
0.100
Why?
Patient Readmission
1
2013
106
0.100
Why?
Academic Medical Centers
1
2013
150
0.100
Why?
Obesity
2
2017
1068
0.100
Why?
Nursing Assessment
1
2011
11
0.100
Why?
Respiratory Tract Infections
1
2012
41
0.100
Why?
Child, Preschool
4
2018
1168
0.100
Why?
Leukocyte Count
3
2017
55
0.100
Why?
Neoplastic Stem Cells
3
2017
90
0.100
Why?
Plant Extracts
1
2012
60
0.100
Why?
Alleles
3
2018
251
0.100
Why?
Up-Regulation
4
2017
183
0.100
Why?
Longitudinal Studies
1
2013
725
0.100
Why?
Gene Duplication
1
2010
5
0.100
Why?
North America
1
2010
33
0.100
Why?
Motor Activity
1
2013
311
0.090
Why?
Stem Cells
1
2013
292
0.090
Why?
Isocitrate Dehydrogenase
1
2010
6
0.090
Why?
Disability Evaluation
1
2011
211
0.090
Why?
Child
5
2018
2221
0.090
Why?
Risk Assessment
6
2012
1313
0.090
Why?
Drug Resistance, Multiple
3
2008
8
0.090
Why?
Leukemia, Myeloid, Chronic-Phase
1
2009
1
0.090
Why?
Benzamides
4
2011
54
0.090
Why?
Drug Screening Assays, Antitumor
2
2007
50
0.090
Why?
Tomography, X-Ray Computed
1
2014
871
0.090
Why?
Histone-Lysine N-Methyltransferase
4
2012
21
0.090
Why?
Polymerase Chain Reaction
3
2017
172
0.090
Why?
Central Nervous System Neoplasms
2
2012
28
0.090
Why?
Topotecan
1
2009
15
0.090
Why?
Antineoplastic Agents, Phytogenic
1
2009
38
0.080
Why?
Leukocytosis
1
2008
8
0.080
Why?
Cardiovascular Diseases
1
2015
1019
0.080
Why?
Tumor Suppressor Protein p53
2
2018
69
0.080
Why?
Genotype
3
2018
735
0.080
Why?
In Situ Hybridization, Fluorescence
2
2009
38
0.080
Why?
Hepatic Veno-Occlusive Disease
1
2007
1
0.080
Why?
Antigens, Differentiation, Myelomonocytic
1
2007
22
0.080
Why?
Asparagine
1
2007
6
0.080
Why?
Sequence Analysis, DNA
2
2017
139
0.070
Why?
Transplantation, Homologous
3
2015
113
0.070
Why?
Diabetes Mellitus, Type 2
1
2015
1383
0.070
Why?
Chromosome Deletion
1
2006
9
0.070
Why?
Polyethylene Glycols
1
2007
66
0.070
Why?
Antigens, CD
1
2007
100
0.070
Why?
Immunophenotyping
2
2007
49
0.070
Why?
RNA, Messenger
3
2017
514
0.070
Why?
Infant, Newborn
2
2018
603
0.070
Why?
Phenotype
3
2012
629
0.060
Why?
Splenomegaly
1
2004
6
0.060
Why?
Anemia, Refractory
1
2004
2
0.060
Why?
Interferon-gamma
1
2004
51
0.060
Why?
Dose-Response Relationship, Drug
3
2015
641
0.060
Why?
Chromosomes, Human, Pair 2
1
2004
5
0.060
Why?
Chromosomes, Human, Pair 11
1
2004
24
0.060
Why?
Fever of Unknown Origin
1
2004
9
0.060
Why?
Vidarabine
1
2003
3
0.060
Why?
Exanthema
1
2004
21
0.060
Why?
Case-Control Studies
2
2017
860
0.060
Why?
Ergocalciferols
1
2003
3
0.060
Why?
Combined Modality Therapy
3
2012
525
0.060
Why?
Urokinase-Type Plasminogen Activator
1
2002
3
0.060
Why?
Statistics, Nonparametric
3
2008
129
0.060
Why?
Diabetes Insipidus, Neurogenic
1
2002
1
0.050
Why?
Bacterial Toxins
1
2002
16
0.050
Why?
Antigens, Bacterial
1
2002
18
0.050
Why?
Monosomy
1
2002
5
0.050
Why?
Chromosomes, Human, Pair 7
1
2002
15
0.050
Why?
Chromosomes, Human, Pair 3
1
2002
28
0.050
Why?
Double-Blind Method
2
2015
504
0.050
Why?
Receptors, Cell Surface
1
2002
72
0.050
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2002
24
0.050
Why?
Chromosome Disorders
1
2002
1
0.050
Why?
Anemia, Aplastic
1
2002
6
0.050
Why?
B-Lymphocytes
1
2002
70
0.050
Why?
Compassionate Use Trials
2
2011
3
0.050
Why?
Bone Marrow Transplantation
1
2002
65
0.050
Why?
Transplantation, Autologous
2
2013
78
0.050
Why?
Survivors
2
2016
145
0.050
Why?
Apoptosis
1
2003
337
0.050
Why?
Cyclophosphamide
3
2005
25
0.050
Why?
Diagnosis, Differential
1
2002
493
0.050
Why?
Gene Frequency
2
2011
225
0.050
Why?
Administration, Oral
2
2011
169
0.040
Why?
Comprehension
1
2019
19
0.040
Why?
Chromosomal Proteins, Non-Histone
1
2018
13
0.040
Why?
Cell Differentiation
2
2016
436
0.040
Why?
Disease Management
1
2019
114
0.040
Why?
Health Personnel
1
2019
111
0.040
Why?
Drug Therapy, Combination
1
2018
273
0.040
Why?
Pathology, Molecular
1
2017
16
0.040
Why?
Antibodies, Blocking
1
2017
3
0.040
Why?
Angiogenic Proteins
1
2017
9
0.040
Why?
Genes, erbB-1
1
2017
15
0.040
Why?
Clone Cells
1
2017
36
0.040
Why?
Genes, p53
1
2017
23
0.040
Why?
Genes, ras
1
2017
26
0.040
Why?
Decision Making
1
2019
180
0.040
Why?
Patient Transfer
1
2017
37
0.040
Why?
Protein Kinase Inhibitors
1
2017
77
0.040
Why?
Genome-Wide Association Study
1
2018
543
0.040
Why?
Physical Examination
1
2016
82
0.030
Why?
Proteins
1
2017
140
0.030
Why?
Body Surface Area
1
2015
14
0.030
Why?
RNA
1
2016
88
0.030
Why?
Genetic Markers
2
2008
122
0.030
Why?
Mental Health
1
2016
104
0.030
Why?
Aziridines
2
2005
3
0.030
Why?
Benzoquinones
2
2005
5
0.030
Why?
Diabetes Mellitus
1
2018
370
0.030
Why?
Patient Discharge
1
2016
169
0.030
Why?
Ribonucleoprotein, U2 Small Nuclear
1
2014
2
0.030
Why?
Antigens, Nuclear
1
2014
6
0.030
Why?
Mobility Limitation
1
2016
187
0.030
Why?
Transcription Factors
1
2016
172
0.030
Why?
Ribonucleoproteins
1
2014
13
0.030
Why?
Sequence Analysis, RNA
1
2014
26
0.030
Why?
Microarray Analysis
1
2014
19
0.030
Why?
Cell Proliferation
1
2017
573
0.030
Why?
Cell Cycle Proteins
1
2014
48
0.030
Why?
Phosphoproteins
1
2014
54
0.030
Why?
Platelet Count
1
2014
21
0.030
Why?
Filgrastim
1
2014
4
0.030
Why?
Granulocyte Colony-Stimulating Factor
1
2014
21
0.030
Why?
Receptors, CXCR
1
2013
3
0.030
Why?
Receptors, CXCR4
1
2013
11
0.030
Why?
Drug Evaluation
1
2013
10
0.030
Why?
Dogs
1
2014
117
0.030
Why?
Smoking
1
2017
439
0.030
Why?
DNA Damage
1
2013
88
0.030
Why?
Epigenesis, Genetic
1
2013
98
0.030
Why?
United States
2
2012
3648
0.030
Why?
Risk
1
2014
290
0.030
Why?
Tumor Stem Cell Assay
2
2003
12
0.030
Why?
Boronic Acids
1
2012
7
0.030
Why?
Antigens, Differentiation, B-Lymphocyte
1
2012
5
0.030
Why?
Peripheral Nervous System
1
2012
6
0.030
Why?
Pyrazines
1
2012
11
0.030
Why?
Histocompatibility Antigens Class II
1
2012
10
0.030
Why?
Cell Division
2
2003
97
0.030
Why?
Drug Synergism
1
2012
67
0.030
Why?
European Continental Ancestry Group
1
2017
1131
0.030
Why?
F-Box Proteins
1
2012
4
0.030
Why?
Injections, Subcutaneous
2
2002
33
0.030
Why?
Ubiquitin Thiolesterase
1
2012
9
0.030
Why?
Body Mass Index
1
2015
867
0.030
Why?
Bone Marrow Cells
2
2003
114
0.030
Why?
Leukemia, Myeloid, Accelerated Phase
1
2011
1
0.030
Why?
Hydroxamic Acids
1
2011
17
0.030
Why?
Exons
1
2011
49
0.030
Why?
Neoplasm Metastasis
1
2012
199
0.030
Why?
Severity of Illness Index
1
2013
864
0.020
Why?
African Americans
1
2017
1373
0.020
Why?
Gene Expression Regulation, Enzymologic
1
2010
83
0.020
Why?
Homeostasis
1
2010
127
0.020
Why?
Nausea
1
2009
49
0.020
Why?
Ideal Body Weight
1
2009
7
0.020
Why?
Diarrhea
1
2009
56
0.020
Why?
Anti-Bacterial Agents
1
2012
285
0.020
Why?
Treatment Refusal
1
2009
10
0.020
Why?
Fatigue
1
2009
69
0.020
Why?
Antigens, CD34
1
2009
54
0.020
Why?
Busulfan
1
2008
4
0.020
Why?
Incidence
1
2012
1123
0.020
Why?
RNA Probes
1
2008
4
0.020
Why?
Isoleucine
1
2007
8
0.020
Why?
Aspartic Acid
1
2007
13
0.020
Why?
Immunotherapy
1
2008
69
0.020
Why?
Analysis of Variance
1
2008
454
0.020
Why?
Expressed Sequence Tags
1
2005
2
0.020
Why?
Stem Cell Transplantation
1
2007
203
0.020
Why?
Chromosomes, Human, Pair 22
1
2004
17
0.020
Why?
Tomography, Emission-Computed
1
2003
25
0.010
Why?
U937 Cells
1
2003
8
0.010
Why?
HL-60 Cells
1
2003
14
0.010
Why?
Blotting, Southern
1
2003
21
0.010
Why?
Cloning, Molecular
1
2003
74
0.010
Why?
Central Nervous System Diseases
1
2003
11
0.010
Why?
Receptors, Urokinase Plasminogen Activator
1
2002
6
0.010
Why?
Cell Cycle
1
2003
69
0.010
Why?
Bacillus anthracis
1
2002
9
0.010
Why?
Thymidine
1
2002
7
0.010
Why?
Partial Thromboplastin Time
1
2002
6
0.010
Why?
Hypocalcemia
1
2002
8
0.010
Why?
Aging
1
2009
881
0.010
Why?
Binding Sites
1
2002
125
0.010
Why?
Blood Cell Count
1
2002
26
0.010
Why?
Liver Failure
1
2002
17
0.010
Why?
Aspartate Aminotransferases
1
2002
28
0.010
Why?
Alanine Transaminase
1
2002
44
0.010
Why?
Cross-Over Studies
1
2002
95
0.010
Why?
Models, Molecular
1
2002
178
0.010
Why?
Tumor Cells, Cultured
1
2002
158
0.010
Why?
Amino Acid Sequence
1
2002
280
0.010
Why?
Renal Insufficiency
1
2002
53
0.010
Why?
Molecular Sequence Data
1
2002
350
0.010
Why?
Drug Delivery Systems
1
2002
93
0.010
Why?
Treatment Failure
1
2002
159
0.010
Why?
Pilot Projects
1
2003
478
0.010
Why?
Cytokines
1
2002
243
0.010
Why?
Powell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (401)
Explore
_
Co-Authors (38)
Explore
_
Similar People (50)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_